Baier, B; Bense, S; Birklein, F et al.
Evidence for Modulation of Opioidergic Activity in Central Vestibular Processing: A [F-18] Diprenorphine PET StudyHUMAN BRAIN MAPPING. Bd. 31. H. 4. 2010 S. 550-555
Debus, F; Herth, MM; Piel, M et al.
F-18-Labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imagingNUCLEAR MEDICINE AND BIOLOGY. Bd. 37. H. 4. 2010 S. 487-495
Boecker, H; Weindl, A; Brooks, DJ et al.
GABAergic Dysfunction in Essential Tremor: An C-11-Flumazenil PET StudyJOURNAL OF NUCLEAR MEDICINE. Bd. 51. H. 7. 2010 S. 1030-1035
Kobiella, A; Vollstadt-Klein, S; Buhler, M et al.
Human Dopamine Receptor D2/D3 Availability Predicts Amygdala Reactivity to Unpleasant StimuliHUMAN BRAIN MAPPING. Bd. 31. H. 5. 2010 S. 716-726
Yakushev, IY; Dupont, E; Buchholz, HG et al.
In vivo imaging of dopamine receptors in a model of temporal lobe epilepsyEPILEPSIA. Bd. 51. H. 3. 2010 S. 415-422
Fottner, C; Mettler, E; Goetz, M et al.
In Vivo Molecular Imaging of Somatostatin Receptors in Pancreatic Islet Cells and Neuroendocrine Tumors by Miniaturized Confocal Laser-Scanning Fluorescence MicroscopyENDOCRINOLOGY. Bd. 151. H. 5. 2010 S. 2179-2188
Miederer, M; Weber, MM; Fottner, C
Molecular Imaging of Gastroenteropancreatic Neuroendocrine TumorsGASTROENTEROLOGY CLINICS OF NORTH AMERICA. Bd. 39. H. 4. 2010 S. 923-+
Huhn, E; Buchholz, HG; Shazly, G et al.
Predicting the in vivo release from a liposomal formulation by IVIVC and non-invasive positron emission tomography imagingEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. Bd. 41. H. 1. 2010 S. 71-77
Helisch, A; Thews, O; Buchholz, HG et al.
Small animal tumour imaging with MRI and the ECAT EXACT scanner: application of partial volume correction and comparison with microPET dataNUCLEAR MEDICINE COMMUNICATIONS. Bd. 31. H. 4. 2010 S. 294-300
Riss, PJ; Piel, M; Bockhart, V et al.
The DAT Ligand [F-18]PR17.MZ Mirrors the in vivo Pharmacokinetic Profile of [C-11]Cocaine with Significantly Improved Monoamine Transporter SelectivityCHEMMEDCHEM. Bd. 5. H. 10. 2010 S. 1686-1688
Werhahn, KJ; Landvogt, C; Buchholz, HG et al.
ALTERATION OF DOPAMINE D2/3 RECEPTOR BINDING IN PATIENTS WITH JUVENILE MYOCLONIC EPILEPSYEPILEPSIA. Bd. 50. 2009 S. 75-75
Werhahn, K; Yakushev, I; Landvogt, C et al.
ARE REDUCTIONS IN D2-RECEPTOR AVAILABILITY REVERSIBLE ONE YEAR AFTER EPILEPSY SURGERY FOR MESIAL TEMPORAL SCLEROSIS?EPILEPSIA. Bd. 50. 2009 S. 135-135
Alessandri, B; Bachli, H; Heimann, A et al.
Blood-induced, but volume-independent changes of brain edema, tissue death and glucose metabolism after acute subdural hematomaJOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. Bd. 29. 2009 S. S31-S31
Miederer, M; Seidl, S; Buck, A et al.
Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in Ga-68-DOTATOC PET/CTEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. Bd. 36. H. 1. 2009 S. 48-52
Horstick, G; Bierbach, B; Abegunewardene, N et al.
Critical Single Proximal Left Arterial Descending Coronary Artery Stenosis to Mimic Chronic Myocardial Ischemia: A New Model Induced by Minimal Invasive TechnologyJOURNAL OF VASCULAR RESEARCH. Bd. 46. H. 4. 2009 S. 290-298
Sebastian, M; Schad, A; Schadmand-Fischer, S et al.
Hemorrhagic pericardial effusion and multiple pulmonary nodules in a 37 year old male who has never smokedINTERNIST. Bd. 50. H. 1. 2009 S. 91-94
Behnke, S; Schroeder, U; Dillmann, U et al.
Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET.Neuroimage. Bd. 47. H. 4. 2009 S. 1237-43
Fellner, M; Dillenburg, W; Buchholz, H et al.
IMAGING OF CHANGES IN P-GLYCOPROTEIN ACTIVITY IN VIVO WITH 68GA-SCHIFF BASE DERIVATIVESJOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. Bd. 52. 2009 S. S394-S394
Miederer, I; Ziegler, SI; Liedtke, C et al.
Kinetic modelling of [C-11]flumazenil using data-driven methodsEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. Bd. 36. H. 4. 2009 S. 659-670
Shah, S; Scholz, A; Reber, H et al.
Laparoscopic radioisotope-guided sentinel lymph node mapping and excision of the rectum-an experimental studyLANGENBECKS ARCHIVES OF SURGERY. Bd. 394. H. 3. 2009 S. 483-487
Yakushev, I; Gerhard, A; Lorscheider, M et al.
Multimodal imaging of the hippocampus in early Alzheimer's diseaseJOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. Bd. 29. 2009 S. S276-S277
Luessi, F; Sollors, J; Zieschang, K et al.
Multiple cranial nerve palsies as presenting symptom in primary Sjogren's syndromeJOURNAL OF NEUROLOGY. Bd. 256. 2009 S. S116-S117
Fehr, C; Grunder, G; Bernow, N et al.
PET IMAGING EXPERIMENTS TO INVESTIGATE POTENTIAL PHARMACOTHERAPEUTIC INTERVENTIONS FOR ALCOHOL DEPENDENCEALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH. Bd. 33. H. 6. 2009 S. 287A-287A
Scheidhauer, K; Miederer, M; Gaertner, FC
PET-CT for neuroendocrine tumors and nuclear medicine therapy optionsRADIOLOGE. Bd. 49. H. 3. 2009 S. 217-223
Schreckenberger, M
Positron emission tomography in substance abuse and addictionNERVENHEILKUNDE. Bd. 28. H. 10. 2009 S. 727-732
Yakushev, I; Hammers, A; Fellgiebel, A et al.
SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging.Neuroimage. Bd. 44. H. 1. 2009 S. 43-50
Drecoll, E; Gaertner, FC; Miederer, M et al.
Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide Bi-213-DTPA-[F3](2) into the Nucleus of Tumor CellsPLOS ONE. Bd. 4. H. 5. 2009 S. -
Schlindwein, P; Schreckenberger, M; Dieterich, M
Visual-Motion Suppression in Congenital Pendular NystagmusAnn N Y Acad Sci. Bd. 1164. 2009 S. 458-60
Kumakura, Y; Vernaleken, I; Buchholz, HG et al.
Age-dependent decline of steady state dopamine storage capacity of human brain: An FDOPA PET study.Neurobiol Aging. 2008 S. 1214-1220
Fehr, C; Yakushev, I; Hohmann, N et al.
Association of low striatal dopamine D2 receptor availabilty with nicotine dependence similar to that seen with other drugs of abuseAm J Psychiatry. Bd. 165. H. 4. 2008 S. 507-514
Vernaleken, I; Kumakura, Y; Buchholz, HG et al.
Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects.Neuroimage. Bd. 40. H. 3. 2008 S. 1222-31
Yakushev, I; Landvogt, C; Buchholz, HG et al.
Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18Psychiatry Res. Bd. 164. H. 2. 2008 S. 143-153
Kienast, T; Hariri, AR; Schlagenhauf, F et al.
Dopamine in amygdala gates limbic processing of aversive stimuli in humans.Nat Neurosci. Bd. 11. H. 12. 2008 S. 1381-1382
Schreckenberger, M; Klega, A; Gründer, G et al.
Opioid receptor PET reveals the psychobiologic correlates of reward processing.J Nucl Med. Bd. 49. 2008 S. 1257-1261
Kobe, C; Dietlein, M; Franklin, J et al.
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphomaBlood. Bd. 112. H. 10. 2008 S. 3989-3994
Kienast, T; Siessmeier, T; Wrase, J et al.
Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuli.Eur J Nucl Med Mol Imaging. Bd. 35. H. 6. 2008 S. 1147-58
Landvogt, C; Mengel, E; Bartenstein, P et al.
Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria.J Cereb Blood Flow Metab. Bd. 28. H. 4. 2008 S. 824-31
Vernaleken, I; Fellows, C; Janouschek, H et al.
Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).J Clin Psychopharmacol. Bd. 28. H. 6. 2008 S. 608-17
Schlindwein, P; Buchholz, HG; Schreckenberger, M et al.
Sympathetic activity at rest and motor brain areas: FDG-PET study.Auton Neurosci. Bd. 143. H. 1-2. 2008 S. 27-32
Struppler, A; Binkofski, F; Angerer, B et al.
A fronto-parietal network is mediating improvement of motor function related to repetitive peripheral magnetic stimulation: A PET-H2O15 studyNeuroimage. Bd. 36 Suppl 2. 2007 S. T174-86
Nickel, O; Helisch, A; Schreckenberger, M
Advantages and problems of digital documentation an reporting in nuclear medicineEur J Nucl Med Mol Imaging. Bd. 34. 2007 S. S393
Vernaleken, I; Weibrich, C; Siessmeier, T et al.
Asymmetry in dopamine D 2/3 receptors of caudate nucleus is lost with age.Neuroimage. Bd. 34. 2007 S. 870-878
Klega, A; Buchholz, HG; Müller, C et al.
Central opioidergic correlates of personality traits in healthy subjectsJ Nucl Med. Bd. 48. 2007 S. 109
Fellgiebel, A; Muller, MJ; Hiemke, C et al.
Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism.World J Biol Psychiatry. Bd. 8. H. 2. 2007 S. 123-6
Kumakura, Y; Cumming, P; Vernaleken, I et al.
Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study.J Neurosci. Bd. 27. H. 30. 2007 S. 8080-7
Fellgiebel, A; Scheurich, A; Bartenstein, P et al.
FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment.Psychiatry Res. Bd. 155. H. 2. 2007 S. 167-71
Tchirikov, M; Schreckenberger, M; Strohner, M et al.
Fetal positron emission tomography during acute hypoxia and after fetoscopic coagulation of major placental vesselsUltrasound Obstet Gynecol. Bd. 30. 2007 S. 435-436
Goetz, M; Fottner, C; Schirrmacher, E et al.
In-vivo confocal real-time mini-microscopy in animal models of human inflammatory and neoplastic diseases.Endoscopy. Bd. 39. H. 4. 2007 S. 350-6
Eichhorn, W; Egle, U; Buchholz, H-G et al.
Neuronal correlates of overt hypothyroidism measured by FDG PETJ Nucl Med. 2007 S. 272
Nickel, O; Helisch, A; Schreckenberger, M
Optimierung der Arbeitsabläufe bei der filmlosen Befunderstellung und BildarchivierungNuklearmedizin. Bd. 46. 2007 S. A83
Helisch, A; Thews, O; Buchholz, HG et al.
PET-Bildgebung von Kleintiertumoren: Dediziertes Kleintier-PET versus klinischer ScannerNuklearmedizin. Bd. 46. 2007 S. A28
Helisch, A; Fottner, C; Reber, H et al.
Pre-therapeutic dosimetry of metastatic neuroendocrine tumors: Implicatons for peptide receptor radiotherapyeingereicht. 2007 S. 1-
Vernaleken, I; Buchholz, HG; Kumakura, Y et al.
Prefrontal cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation.Hum Brain Mapp. Bd. 28. 2007 S. 931-939
Landvogt, C
SPECT und PET in der Diagnostik von EpilepsienDer Nuklearmediziner. Bd. 3. 2007 S. 212-216
Fehr, C; Hohmann, N; Grunder, G et al.
Tiagabine does not attenuate alcohol-induced activation of the human reward system.Psychopharmacology. Bd. 191. H. 4. 2007 S. 975-83
Klega, A; Buchholz, HG; Müller, C et al.
Untersuchung zentraler opioiderger Korrelate von Persönlichkeitsmerkmalen gesunder ProbandenNuklearmedizin. Bd. 46. 2007 S. A56
Schreckenberger, M
"Ecstasy"-induced neurotoxicity: the contribution of functional brain imagingEur J Nucl Med Mol Imaging. Bd. 33. H. 2. 2006 S. 185-7
Helisch, A; Fottner, C; Schreckenberger, M et al.
1. Überlegenheit der F-18-DOPA-PET vs. Iod-123-MIBG-Szintigraphie zur präoperativen Lokalisation von extraadrenalen und multifokalen PhäochromozytomenParagangliomen. 44. Jahrestagung Nuklearmedizin Berlin,. 2006 S. V190
Bense, S; Best, C; Buchholz, HG et al.
18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.Neuroreport. Bd. 17. H. 6. 2006 S. 599-603
Schirrmacher, R; Bradtmoller, G; Schirrmacher, E et al.
18F-labeling of peptides by means of an organosilicon-based fluoride acceptorAngew Chem Int Ed Engl. Bd. 45. H. 36. 2006 S. 6047-50
Fottner, C; Rossmann, H; Schamberger, B et al.
A novel succinate dehydrogenase subunit D (SDHD) gene mutation, F136frameshift, causes familial malignant extraadrenal paragangliomas. 50th Annual Meeting of the German Society of EndocrinologyExp Clin Endocr Diab. Bd. 114. 2006 S. P05-060
Nguyen-Huu, BK; Urban, PP; Schreckenberger, M et al.
Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer.Mov Disord. Bd. 21. H. 8. 2006 S. 1285-7
Kunkel, Martin; Helisch, Andreas; Reichert, Torsten E. et al.
Clinical and prognostic value of [18F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapyOral oncology. OO. Bd. 42. H. 3. Kidlington: Elsevier Science 2006 S. 297 - 305
Werhahn, KJ; Landvogt, C; Klimpe, S et al.
Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET studyEpilepsia. Bd. 47. H. 8. 2006 S. 1392-6
Vander Borght, T; Asenbaum, S; Bartenstein, P et al.
EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues.Eur J Nucl Med Mol Imaging. Bd. 33. H. 11. 2006 S. 1374-80
Teipel, SJ; Drzezga, A; Bartenstein, P et al.
Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial.Psychopharmacology. Bd. 187. H. 1. 2006 S. 86-94
Buchmann, I; Hansen, T; Brochhausen, C et al.
FDG-PET in the initial staging of squamous cell oesophageal carcinoma.Nuklearmedizin. Bd. 45. H. 6. 2006 S. 235-41
Baumgartner, U; Buchholz, HG; Bellosevich, A et al.
High opiate receptor binding potential in the human lateral pain system.Neuroimage. Bd. 30. H. 3. 2006 S. 692-9
Vernaleken, I; Kumakura, Y; Cumming, P et al.
Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challengeNeuroimage. Bd. 30. H. 4. 2006 S. 1332-1339
Siessmeier, T; Kienast, T; Wrase, J et al.
Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.Eur J Neurosci. Bd. 24. H. 1. 2006 S. 305-13
Schreckenberger, MF; Egle, UT; Drecker, S et al.
Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidismJ Clin Endocrinol Metab. Bd. 91. 2006 S. 4786-91
Teipel, SJ; Willoch, F; Ishii, K et al.
Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.Neurobiol Aging. Bd. 27. H. 5. 2006 S. 681-90
Fottner, C; Helisch, A; Schreckenberger, M et al.
Superiority of 6-[18F]-Fluorodopamin Positron Emission Tomography (DOPA-PET) versus [123J]-Metaiodobenzylguanidine (MIBG) Scintigraphy in the localization of extraadrenal or multifocal pheochromocytomas and paragangliomoas. 50th Annual Meeting of the German Society of EndocrinologyExp Clin Endocr Diab. Bd. 114. 2006 S. P01-002
Schirrmacher, E; Beck, C; Brueckner, B et al.
Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferases.Bioconjug Chem. Bd. 17. H. 2. 2006 S. 261-6
Gründer, G; Landvogt, C; Vernaleken, I et al.
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.Neuropsychopharmacology. Bd. 31. H. 5. 2006 S. 1027-35